Literature DB >> 32103476

To drop or not to drop the antiplatelet agent, that is the question for patients with atrial fibrillation and chronic coronary syndrome undergoing percutaneous coronary intervention.

Yongcheol Kim1, Thomas W Johnson2, Young-Hoon Jeong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32103476      PMCID： PMC8086494          DOI： 10.5603/CJ.2020.0012

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  9 in total

1.  Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Authors:  Renato D Lopes; Gretchen Heizer; Ronald Aronson; Amit N Vora; Tyler Massaro; Roxana Mehran; Shaun G Goodman; Stephan Windecker; Harald Darius; Jia Li; Oleg Averkov; M Cecilia Bahit; Otavio Berwanger; Andrzej Budaj; Ziad Hijazi; Alexander Parkhomenko; Peter Sinnaeve; Robert F Storey; Holger Thiele; Dragos Vinereanu; Christopher B Granger; John H Alexander
Journal:  N Engl J Med       Date:  2019-03-17       Impact factor: 91.245

2.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

3.  Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.

Authors:  Yukiko Matsumura-Nakano; Satoshi Shizuta; Akihiro Komasa; Takeshi Morimoto; Hisaki Masuda; Hiroki Shiomi; Koji Goto; Kentaro Nakai; Hisashi Ogawa; Atsushi Kobori; Yutaka Kono; Kazuaki Kaitani; Satoru Suwa; Takeshi Aoyama; Mamoru Takahashi; Yasuhiro Sasaki; Yuko Onishi; Toshiaki Mano; Mitsuo Matsuda; Makoto Motooka; Hirofumi Tomita; Moriaki Inoko; Takatoshi Wakeyama; Nobuhisa Hagiwara; Kengo Tanabe; Masaharu Akao; Katsumi Miyauchi; Junji Yajima; Keiichi Hanaoka; Yoshihiro Morino; Kenji Ando; Yutaka Furukawa; Yoshihisa Nakagawa; Koichi Nakao; Ken Kozuma; Kazushige Kadota; Kazuo Kimura; Kazuya Kawai; Takafumi Ueno; Ken Okumura; Takeshi Kimura
Journal:  Circulation       Date:  2019-01-29       Impact factor: 29.690

4.  Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.

Authors:  Satoshi Yasuda; Koichi Kaikita; Masaharu Akao; Junya Ako; Tetsuya Matoba; Masato Nakamura; Katsumi Miyauchi; Nobuhisa Hagiwara; Kazuo Kimura; Atsushi Hirayama; Kunihiko Matsui; Hisao Ogawa
Journal:  N Engl J Med       Date:  2019-09-02       Impact factor: 91.245

5.  2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).

Authors:  Gregory Y H Lip; Jean-Phillippe Collet; Michael Haude; Robert Byrne; Eugene H Chung; Laurent Fauchier; Sigrun Halvorsen; Dennis Lau; Nestor Lopez-Cabanillas; Maddalena Lettino; Francisco Marin; Israel Obel; Andrea Rubboli; Robert F Storey; Marco Valgimigli; Kurt Huber
Journal:  Europace       Date:  2019-02-01       Impact factor: 5.214

6.  Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.

Authors:  Pascal Vranckx; Marco Valgimigli; Lars Eckardt; Jan Tijssen; Thorsten Lewalter; Giuseppe Gargiulo; Valerii Batushkin; Gianluca Campo; Zoreslava Lysak; Igor Vakaliuk; Krzysztof Milewski; Petra Laeis; Paul-Egbert Reimitz; Rüdiger Smolnik; Wolfgang Zierhut; Andreas Goette
Journal:  Lancet       Date:  2019-09-03       Impact factor: 79.321

7.  Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome.

Authors:  Antonio Gabriele Franchina; Dario Calderone; Paolo D'Arrigo; Salvatore Ingala; Rocco Paolo Milluzzo; Antonio Greco; Marco Spagnolo; Corrado Tamburino; Davide Capodanno
Journal:  Cardiol J       Date:  2020-01-21       Impact factor: 2.737

8.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Authors:  C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox
Journal:  N Engl J Med       Date:  2016-11-14       Impact factor: 91.245

Review 9.  Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Philip Urban; Roxana Mehran; Roisin Colleran; Dominick J Angiolillo; Robert A Byrne; Davide Capodanno; Thomas Cuisset; Donald Cutlip; Pedro Eerdmans; John Eikelboom; Andrew Farb; C Michael Gibson; John Gregson; Michael Haude; Stefan K James; Hyo-Soo Kim; Takeshi Kimura; Akihide Konishi; John Laschinger; Martin B Leon; P F Adrian Magee; Yoshiaki Mitsutake; Darren Mylotte; Stuart Pocock; Matthew J Price; Sunil V Rao; Ernest Spitzer; Norman Stockbridge; Marco Valgimigli; Olivier Varenne; Ute Windhoevel; Robert W Yeh; Mitchell W Krucoff; Marie-Claude Morice
Journal:  Circulation       Date:  2019-05-22       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.